| 000 | 01857 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515225203.0 | ||
| 264 | 0 | _c20100721 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1473-5741 | ||
| 024 | 7 |
_a10.1097/cad.0b013e32833a4385 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSen, Triparna | |
| 245 | 0 | 0 |
_aEpigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _cJul 2010 |
||
| 300 |
_a632-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnticarcinogenic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBreast Neoplasms _xenzymology |
| 650 | 0 | 4 |
_aCarrier Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCatechin _xanalogs & derivatives |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aExtracellular Matrix Proteins _xmetabolism |
| 650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFocal Adhesion Protein-Tyrosine Kinases _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xmetabolism |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism |
| 650 | 0 | 4 |
_aTranscription Factor AP-1 _xmetabolism |
| 700 | 1 | _aDutta, Anindita | |
| 700 | 1 | _aChatterjee, Amitava | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 21 _gno. 6 _gp. 632-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/cad.0b013e32833a4385 _zAvailable from publisher's website |
| 999 |
_c19878162 _d19878162 |
||